EFTA02617149.pdf

From: <[email protected]> Sent: Saturda , November 3, 2018 7:06 PM To: Subject: Re: Call ne before sending anything On Sat, Nov 3, 2018 at 7:=1 PM < <mailto > > =rote: Hi Boris Currently The F=male Health division of VERU supplies approximately 50 million Female Cond=ms worldwide. BMGF has never funded the FC2 Female condom. =AO I don't know why this is the case. The FC2 female =ondom is the most demanded and utilized female condom worldwide. =A0lt is supplied throughout Africa via UNFPA and bought directly by =outh Africa. Funding by UNFPA has drama=ically decreased and we are unable to supply certain countries that have r=quested the female condom. For example, the following count=ies have requested the FC2 female condom but we are unable to supply: Uganda : 3 million units =A0 Ghana: 1 million units Botswana: 1 million units=C2 Tunesia: 1 million units Sierra Leone: 500,000 units =A0 Bolivia: 500,000 units<=span> Tanzania: 1 million units=C2 Haiti: 500,000 units Ethiopia: 1 million units =A0 Congo DR: 2 million units Boris= can you introduce me to the right person at BMGF to see if we can get gra=ts to provide FC2 female condoms to all women who request them in Africa.<=font> Also attached is more information regarding the FC2 female c=ndom. Would like to continue the conversation. Sincerely, Harry EFTA_R1_01818572 EFTA02617149  -riginal Message From: Boris Nikolic < <mailto = target=» To: harryfisch < mailto >> Cc: jeevacation <[email protected] <mailto:[email protected]» Sent: Sat, Nov 3, 2018 1:27 pm Subject: RE: Re: Thank you Harry! Again — great=meeting you. I am still laughing re inherited STD. Finally I had chance =4::, read your slide deck. VERU is indeed very interesting company — =ongrats! You have an interesti=g mix of Urology specialty drugs (which I see as a low risk) and Prostate =ancer drugs. Unfortunately my fund=(https://w=w.biomaticscapital.com/ <https://www.biomaticscapital.com/> ) is only focused (and restricted to investing)=on private companies. Mid-end of the next y=ar I am going to fundraise a crossover fund which would allow me to invest=in both private and publicly listed companies; nevertheless, I am now unab=e to invest in companies such as VERU — despite how interesting they might be. I looked at a female =ondom. I think that PATH supported a number of related projects. https://www.path.org/artic=es/seven-secrets-of-the-female-condom/ <https://www.path.org/artides/seven•=ecrets-of- the-female-condomk As you might know BMG= is the main donor to PATH — this is why I mentioned it. Also BMGF founded sev=ral smaller grants (GCE) re female condoms https://www.gatesfoundation.org/Media- Center/Press-Releases/2014/06/GCE-Rowd-12 <https://www.gatesfoundation.org/Medi=-Center/Press- Releases/2014/06/GCE-Round-12> In addition, there we=e grants to Imperial College in London, HealthRock etc. All of these are rela=ively old grants that ended. My guess is that all female condom more matur= projects transitioned to PATH. Also I see that PSI h=s been funding marketing and delivery https://www.psi.org/2018/03/fresh-start-female- condom-marketing/ Please let me know if=there is anything else I can be of help to you. Hope to see you soon =n NYC Best Boris From: Sent: Thursday, November 1, 2018 5:34 PM To: Boris Nikolic «mailto <mak° »; [email protected]=> Subject: Re: Jeffrey th=nks for introducing me to Boris. 2 EFTA_R1_01818573 EFTA02617150  Boris, gre=t meeting you as well. Attached i= the most recent deck for VERU (NASDAQ: VERU), www.verupharma.com <http://www.verupharma.com> . In additio= please look at www.femalecondom.com <http://www.femalecondom.com> . We merged with The Female Health Comp=ny which sells the FC2 Female Condom to the public sector in Africa and Br=zil via UNFPA and USAID. We just recently introduced this condom int= the US market mainly via telemedicine. Would love=to meet and discuss further. Sincerely,=/span> Harry Harry Fisc= MD cel Original Message From: Boris Nikolic < <mailto >> To:1 <'eevacation@ mail.com <mailto:[email protected]=m»; Harry Fisch < <mailto: Sent: Thu, Nov 1, 2018 4:13 pm Subject: RE: Thank you J! Great meeting you Harry! Looking forward to seeing you again. Please send me something re your company. Best Boris From: J <[email protected] <mailto:[email protected]» Sent: Thursday, November 1, 2018 3:15 PM To: Boris Nikolic < <mailto »; Harry Fisch Subject: harry boris , boris harry please note The information contained in this communication is confidential, may be attorney-client privileged, may constitute inside information, and is intended only for the use of the addressee. It is the property of JEE Unauthorized use, disclosure or copying of this communication or any part thereof is strictly prohibited 3 EFTA_R1_01818574 EFTA02617151  and may be unlawful. If you have received this communication in error, please notify us immediately by return e-mail or by e-mail to [email protected], and including all attachments. copyright -all rights reserved =AO please note The information contained i= this communication is confidential, may be attorney-client privileged,=may constitute inside information, and is intended only for the use =1 the addressee. It is the property of JEE Unauthorized use, disclos=re or copying of this communication or any part thereof is strictly pro=ibited and may be unlawful. If you have received this communication =n error, please notify us immediately by return e-mail or by e-mail to =a href="mailto:[email protected]" target="_blank">jeevacation@gmai=.com, and destroy this communication and all copies thereof, inc=uding all attachments. copyright -all rights reserved conversation-id 9094 date-last-viewed 0 date-received 1541271966 flags 8590195713 remote-id 868465 4 EFTA_R1_01818575 EFTA02617152